Demographic and survival characteristics of untreated hepatocellular carcinoma patients: insights into the natural history and prognostic determinants.

IF 2.7 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Helena González-Sánchez, Andrés Castaño-García, Miriam Celada-Sendino, Pablo Flórez-Díez, Marta García-Calonge, Manuel Rodríguez, Valentina Chiminazzo, María Varela Calvo
{"title":"Demographic and survival characteristics of untreated hepatocellular carcinoma patients: insights into the natural history and prognostic determinants.","authors":"Helena González-Sánchez, Andrés Castaño-García, Miriam Celada-Sendino, Pablo Flórez-Díez, Marta García-Calonge, Manuel Rodríguez, Valentina Chiminazzo, María Varela Calvo","doi":"10.17235/reed.2025.11029/2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hepatocellular carcinoma (HCC) patients with advanced symptoms or liver failure are often ineligible for transplantation, leading only to symptom control. Additionally, various factors lead to other HCC stage patients remaining in natural history.</p><p><strong>Objective: </strong>To describe the demographic of untreated HCC patients and to analyze survival-influencing factors.</p><p><strong>Methods: </strong>single-center retrospective observational study examining HCC patients diagnosed from 2015 to 2021 who received symptom control as their primary treatment. Baseline characteristics and survival data were collected and analyzed.</p><p><strong>Results: </strong>Of 685 HCC patients, 26% (n=181) remained in natural history, median age 71 years, 82% male patients, 93% with cirrhosis, 53% with previous decompensation. At a mean follow-up of 9.98 months, the mortality rate was 84%. While 49.8% of patients were BCLC-D stage, other reasons for remaining in natural history included frailty (25.4%) comorbidities (16%), and patient's treatment refusal (8%). Independent survival factors were BCLC stage, previous decompensation and diagnosis within the screening program, with 37% of untreated patients detected through surveillance.</p><p><strong>Conclusions: </strong>Liver function, BCLC stage and functional status influence survival in natural HCC history. A significant 37% diagnosed through screening indicates inclusion criteria refinement necessity to avoid overdiagnosis and optimize resources.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Enfermedades Digestivas","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17235/reed.2025.11029/2024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hepatocellular carcinoma (HCC) patients with advanced symptoms or liver failure are often ineligible for transplantation, leading only to symptom control. Additionally, various factors lead to other HCC stage patients remaining in natural history.

Objective: To describe the demographic of untreated HCC patients and to analyze survival-influencing factors.

Methods: single-center retrospective observational study examining HCC patients diagnosed from 2015 to 2021 who received symptom control as their primary treatment. Baseline characteristics and survival data were collected and analyzed.

Results: Of 685 HCC patients, 26% (n=181) remained in natural history, median age 71 years, 82% male patients, 93% with cirrhosis, 53% with previous decompensation. At a mean follow-up of 9.98 months, the mortality rate was 84%. While 49.8% of patients were BCLC-D stage, other reasons for remaining in natural history included frailty (25.4%) comorbidities (16%), and patient's treatment refusal (8%). Independent survival factors were BCLC stage, previous decompensation and diagnosis within the screening program, with 37% of untreated patients detected through surveillance.

Conclusions: Liver function, BCLC stage and functional status influence survival in natural HCC history. A significant 37% diagnosed through screening indicates inclusion criteria refinement necessity to avoid overdiagnosis and optimize resources.

未经治疗的肝细胞癌患者的人口统计学和生存特征:自然史和预后决定因素的见解。
背景:晚期症状或肝功能衰竭的肝细胞癌(HCC)患者往往不适合移植,只能控制症状。此外,各种因素导致其他HCC期患者仍存在于自然史中。目的:描述未经治疗的HCC患者的人口学特征,并分析其生存的影响因素。方法:采用单中心回顾性观察研究,对2015 - 2021年确诊并以症状控制为主要治疗手段的HCC患者进行研究。收集和分析基线特征和生存数据。结果:在685例HCC患者中,26% (n=181)保持自然史,中位年龄71岁,82%为男性,93%为肝硬化,53%为既往失代偿。平均随访9.98个月,死亡率为84%。49.8%的患者为BCLC-D期,其他留在自然史的原因包括虚弱(25.4%)、合并症(16%)和患者拒绝治疗(8%)。独立的生存因素是BCLC分期、既往失代偿和筛查计划内的诊断,37%的未治疗患者通过监测被发现。结论:肝功能、BCLC分期和功能状态影响自然HCC患者的生存。通过筛查诊断的显著37%表明纳入标准需要改进,以避免过度诊断和优化资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
25.00%
发文量
400
审稿时长
6-12 weeks
期刊介绍: La Revista Española de Enfermedades Digestivas, Órgano Oficial de la Sociedad Española de Patología Digestiva (SEPD), Sociedad Española de Endoscopia Digestiva (SEED) y Asociación Española de Ecografía Digestiva (AEED), publica artículos originales, editoriales, revisiones, casos clínicos, cartas al director, imágenes en patología digestiva, y otros artículos especiales sobre todos los aspectos relativos a las enfermedades digestivas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信